Mattia Galli/LinkedIn
Dec 19, 2025, 12:07
OCEAN Trial: Rethinking Long-term Anticoagulation after Atrial Fibrillation Ablation
Mattia Galli, Assistant Professor at Sapienza University of Rome, Associate Editor of European Heart Journal, posted on LinkedIn:
”Can we drop oral anticoagulant therapy after successful atrial fibrillation ablation?”
Read the full article here.
Title: OCEAN trial: rethinking long-term anticoagulation after atrial fibrillation ablation
Authors: Mattia Galli, Beatrice Simeone, Sebastiano Sciarretta

Stay updated with Hemostasis Today.
Anticoagulation
Atrial Fibrillation
Atrial Fibrillation Ablation
Beatrice Simeone
Cardiology
ESC
European Heart Journal
European Society of Cardiology
Health
Heart Health
Hematology
Hemostasis
Hemostasis Today
Long-term Anticoagulation
Mattia Galli
Medicine
OCEAN Trial
Sapienza University of Rome
Sebastiano Sciarretta
thrombosis
-
Nov 21, 2026, 20:00Jeyda Star: The FAST Signs of Stroke and the Reality of Life Afterward
-
Nov 21, 2026, 19:59Daniel Lindholm: Women Showed the Largest Improvement in Stroke Risk Over Time in Heart Failure
-
Nov 21, 2026, 19:56Neil Arrowsmith: Raising Awareness of Pulmonary Embolism in Young People
-
Nov 21, 2026, 19:52Muhammad Zeeshan Jamal: Thrilled to Present Our Research on Intermediate-Risk Acute PE in Abu Dhabi
-
Nov 21, 2026, 19:50Mounisha Devireddy: Proud to Share Our Research on High-Risk PE in Pregnancy
-
Nov 21, 2026, 19:47Melissa Hollo: How Severe Anemia Increases the Odds of Acute HF During Pregnancy and Postpartum
-
Nov 21, 2026, 19:44Ashenafi Tazebew Amare: Building Sustainable Systems to Close the Anti-D Immunoglobulin Access Gap in LMICs
-
Nov 21, 2026, 19:43Sheharyar Raza: Interpreting Clotting Times Through Reptilase Time and Thrombin Time Assays
-
Nov 21, 2026, 19:42Minoo Ahmadinejad: Serving on the ISTH 2027 Scientific Theme Committee for Women’s Health